Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Morningstar Executive Chairman Joseph D. Mansueto Sells $5.09M of Stock
Joseph D. Mansueto, Executive Chairman, sold 21,378 shares of Morningstar, Inc. at $227.57 to $244.51 a share (average $238.09) in 20 transactions, worth $5.09M in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 8,594,429 (-0.0%).
TrueBlue delivered a strong Q3 beat driven by 100% growth in energy sector revenue and significant operating leverage, leading to a robust Q4 revenue growth outlook of 20% to 24%.
GoDaddy Chief Strategy & Legal Officer Jared F. Sine Sells $118K of Stock
Jared F. Sine, Chief Strategy & Legal Officer, sold 1,000 shares of GoDaddy Inc. at $117.80 a share, worth $118K in total on Nov 2, 2026. Shares held after the trade: 69,164 (-1.4%).
Arista Networks Insider Mark B. Templeton Sells $829K of Stock
Mark B. Templeton sold 5,000 shares of Arista Networks, Inc. at $164.07 to $168.85 a share (average $165.85) in 5 transactions, worth $829K in total on Nov 2, 2026. Shares held after the trade: 43,410 (-1.1%).
Lyntris Inc. delivered record revenue and strong cash flow, though margins faced compression due to early-stage design and development work on major defense programs.
EverQuote CEO and President Jayme Mendal Sells $501K of Stock
Jayme Mendal, CEO and President, sold 20,981 shares of EverQuote, Inc. at $23.82 to $24.27 a share (average $23.88) in 2 transactions, worth $501K in total on Nov 2, 2026. Shares held after the trade: 548,253 (-0.5%).
Japan Smaller Capitalization Fund Insider Saba Capital Management L.P. Sells $179K of Stock
Saba Capital Management L.P. sold 16,200 shares of Japan Smaller Capitalization Fund Inc at $11.07 a share, worth $179K in total on Nov 3, 2026. Shares held after the trade: 2,808,632 (-0.6%).
Sinclair delivered a record political revenue quarter, significantly raising full-year EBITDA guidance while prioritizing debt reduction and strategic market optimization over a standalone ventures spin-off.
Pinterest Insider Benjamin Silbermann Sells $1.92M of Stock
Benjamin Silbermann sold 93,750 shares of Pinterest, Inc. at $19.92 to $21.00 a share (average $20.46) in 2 transactions, worth $1.92M in total between Nov 3, 2026 and Nov 4, 2026. Shares held after the trade: 0 (-100.0%).
Vesta Real Estate Corporation, S.A.B. de C.V Chief Portfolio Officer Carranza Diego Berho Sells $109K of Stock
Carranza Diego Berho, Chief Portfolio Officer, sold 30,000 shares of Vesta Real Estate Corporation, S.A.B. de C.V. at $3.64 a share, worth $109K in total on Nov 3, 2026. Shares held after the trade: 1,681,661 (-1.8%).
CoinShares Director Daniel Masters Sells $394K of Stock
Daniel Masters, Director, sold 100,000 shares of CoinShares PLC at $3.85 to $3.98 a share (average $3.94) in 3 transactions, worth $394K in total between Nov 2, 2026 and Nov 4, 2026. Shares held after the trade: 21,410,245 (-0.2%).
VIAVI delivered a significant beat-and-raise quarter driven by 56.9% year-over-year revenue growth, fueled by AI-driven data center demand and the successful integration of Spirent, leading to an accelerated $2 billion revenue run rate target.
Caseys General Stores Chief Merch. Officer Thomas P. Brennan Jr. Sells $2.36M of Stock
Thomas P. Brennan Jr., Chief Merch. Officer, sold 3,000 shares of Caseys General Stores Inc at $779.88 to $799.83 a share (average $786.53) in 2 transactions, worth $2.36M in total on Jun 29, 2026. Shares held after the trade: 11,171 (-15.2%).
Takeda Pharmaceutical Co President, OBU Teresa Marie Bitetti Sells $974K of Stock
Teresa Marie Bitetti, President, OBU, sold 46,609 shares of Takeda Pharmaceutical Co Ltd at $20.89 a share, worth $974K in total on Nov 2, 2026. Shares held after the trade: 214,501 (-17.9%).
Porch Group COO Matthew Neagle Sells $1.17M of Stock
Matthew Neagle, COO, sold 56,250 shares of Porch Group, Inc. at $20.71 to $21.29 a share (average $20.88) in 2 transactions, worth $1.17M in total on Nov 2, 2026. Shares held after the trade: 1,736,756 (-1.0%).
Corebridge Financial 10% Owner Nippon Life Insurance Co Buys $6.7M of Stock
Nippon Life Insurance Co, 10% Owner, bought 190,251 shares of Corebridge Financial, Inc. at $35.23 a share, worth $6.7M in total on Nov 2, 2026. Shares held after the trade: 132,534,113 (+0.1%).
Warrior Met Coal delivered strong Q3 2026 results with 48% sales volume growth driven by Blue Creek, generating $139 million free cash flow and supporting a $2 per share special dividend despite Mine 7 geological challenges.
Kinetik Holdings reported Q3 2026 financial results with record processed gas volumes of 1.94 Bcf/d and net income of $50.9 million. The company reached a final investment decision on the ECCC Pipeline expansion and expects full-year 2026 Adjusted EBITDA to be at the high end of its $1.04 billion to $1.1 billion guidance range.
“Kinetik delivered another strong quarter with record processed gas volumes underscoring the strength and increasing scale of our business. As our strategic growth projects come online and processed gas volumes continue to increase, our financial performance is increasingly driven by durable, repeatable earnings.”
Jamie Welch, Kinetik’s President & Chief Executive Officer
“The momentum we have built throughout the year has continued into the fourth quarter. Producer activity remains strong, processed gas volumes are tracking toward our approximately 2.2 Bcf/d fourth quarter 2026 target, and margins and costs continue to outperform our internal budget expectations.”
Jamie Welch, Kinetik’s President & Chief Executive Officer
Outset Medical reported total revenue of $33.6 million for the third quarter of 2026, an increase from $29.4 million in the prior year period. The company reduced its quarterly net loss to $14.7 million compared to $17.8 million in Q3 2025, driven by improved gross margins and lower operating expenses.
Medicus Pharma announced that its wholly-owned subsidiary, SkinJect, Inc., has entered into a non-binding letter of intent for a business combination with an undisclosed SPAC. The proposed transaction contemplates a $135 million pre-money enterprise valuation for SkinJect and is expected to close in the first half of 2027, with Medicus seeking to retain majority ownership.
Value
$135M
“We believe this proposed transaction will represent a meaningful step toward executing our strategic mandate to unlock the value of this important clinical-stage asset for our shareholders. The proposed transaction, in addition to establishing an independent public-market platform and access for Skinject, will also allow Medicus to participate in its future growth”
For the three months ended September 30, 2026, McKesson reported revenues of $111.0 billion, a 7.6% increase year-over-year, and net income attributable to the corporation of $1.2 billion. The company's balance sheet shows a significant increase in total assets to $92.3 billion, primarily driven by higher cash and inventory levels, while stockholders' deficit widened to $4.0 billion.
Niagen Bioscience is navigating a transitional 2026 investment year, focusing on new salt forms and pharmaceutical pipelines to offset current revenue declines and ingredient pricing pressure.
Dime Commercial Bancshares Director Basswood Capital Management L.L.C. Sells $2.72M of Stock
Basswood Capital Management L.L.C., Director, sold 63,678 shares of Dime Commercial Bancshares, Inc. at $42.72 a share, worth $2.72M in total between Nov 2, 2026 and Nov 3, 2026. Shares held after the trade: 349,794 (-2.6%).
NewLake Capital Partners reported third quarter 2026 financial results with revenue of $12.0 million and net income of $4.2 million. The company strengthened its balance sheet by repaying all outstanding debt, ending the quarter with $17.9 million in cash and no debt. Additionally, the board extended the company's stock repurchase program through December 31, 2028, with $8.2 million remaining in authorization.
“Our third quarter financial results were in line with our expectations, and year to date we collected 99.7% of contractual rent. Notably, we strengthened our balance sheet by repaying $7.6 million of debt, ending the quarter with no debt outstanding and $17.9 million in cash.”
Anthony Coniglio, NewLake’s President and Chief Executive Officer
“With a disciplined focus on property-level cash flow, a debt-free balance sheet and available credit capacity, we believe NewLake is well positioned to pursue growth opportunities as the cannabis regulatory landscape matures.”
Anthony Coniglio, NewLake’s President and Chief Executive Officer
cbdMD M&A Deal with Twinlab Consolidated Holdings, Inc.
cbdMD, Inc. completed the acquisition of the operating assets and brands of Twinlab Consolidated Holdings, including the Twinlab, Reserveage, and Metabolife brands, through a Florida assignment for the benefit of creditors proceeding. The consideration included the assumption of senior secured debt and the issuance of approximately 2.23 million shares of common stock to the secured creditor. The deal diversifies cbdMD's portfolio beyond hemp-derived products into the broader nutritional supplement and wellness market.
Bio Green Med Solution Nasdaq/NYSE Compliance Notice
Bio Green Med Solution received a deficiency notice from Nasdaq on October 29, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until April 27, 2027, to regain compliance and is considering a reverse stock split as a potential remedy in connection with its pending business combination with Future NRG Sdn. Bhd.
Nature’s Sunshine Products reported third quarter 2026 net sales of $116.6 million, a 9% decrease compared to the prior year, driven by operational disruptions in China and challenges in its Digital business. GAAP net income fell to $1.9 million, or $0.11 per diluted share, down from $5.3 million in the same period last year.
Term
Q3 2026
“Our third-quarter results were disappointing and fell short of our expectations. We faced several challenges in our business, particularly in China and in our Digital business.”
Ken Romanzi, CEO of Nature’s Sunshine
“While our third quarter performance was far from our expectations, our confidence in the long-term potential of Nature's Sunshine remains strong.”
The filing details Prospect Capital Corp's investment portfolio as of September 30, 2026, highlighting a diverse range of holdings across sectors such as Consumer Finance, Energy, and Structured Finance. Notable investments include significant positions in CP Energy Services, First Tower Finance, and various CLO structured notes.